John Muscalus
Family Medicine · Hummelstown, PANPI 1710919774
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,376 and has fallen 78.8% since, to $292 in 2023.
Across 316 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$700
- Takeda Pharmaceuticals U.S.A., Inc.$442
- Novo Nordisk$392
- Sanofi-aventis U.S. LLC$290
- GSK$278
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,054100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 36 | $1,002 |
| AbbVie(2 entities) | 54 | $700 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $442 |
| Novo Nordisk | 22 | $392 |
| Sanofi-aventis U.S. LLC | 20 | $290 |
| GSK | 23 | $278 |
| Amgen | 17 | $257 |
| Merck | 14 | $231 |
| Boehringer Ingelheim | 14 | $217 |
| Pfizer | 19 | $186 |
| Amarin Pharma, Inc. | 12 | $180 |
| Johnson & Johnson | 9 | $144 |
| E.r. Squibb & Sons, L.L.C. | 9 | $143 |
| Lilly USA, LLC | 9 | $136 |
| Eisai Inc. | 4 | $111 |
| Kowa Pharmaceuticals America, Inc. | 4 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Mylan Specialty L.p. | 2 | $28 |
| Astellas Pharma US Inc | 2 | $28 |
| Abbott | 2 | $27 |
| Bausch Health US, LLC | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Mannkind Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,060 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 27 | $336 |
| Metoprolol Succinate | 15 | $304 |
| Omeprazole | 14 | $247 |
| Rosuvastatin Calcium | 11 | $234 |
| Simvastatin | 17 | $177 |
| Escitalopram Oxalate | 11 | $149 |
| Amlodipine Besylate | 16 | $66 |
| Metformin Hcl | 13 | $57 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Hummelstown
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.